Advertisement

U.S. markets open in 5 hours 25 minutes

S&P Futures
4,384.00
+35.00(+0.80%)
Dow Futures
34,423.00
+238.00(+0.70%)
Nasdaq Futures
14,301.00
+160.25(+1.13%)
Russell 2000 Futures
2,021.40
+20.10(+1.00%)
Crude Oil
85.85
+0.25(+0.29%)
Gold
1,844.30
-8.20(-0.44%)

Advertisement

BioDelivery Sciences International, Inc. (BDSI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

3.7200

+0.0300

(+0.81%)

At close: 04:00PM EST

3.6700

-0.05

(-1.34%)

After hours:

07:56PM EST

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	3.6900
Open	3.6400
Bid	0.0000 x 3100
Ask	0.0000 x 4000
Day's Range	3.4900 - 3.7300
52 Week Range	2.5000 - 4.6800
Volume	2,024,771
Avg. Volume	1,648,090

Market Cap	367.521M
Beta (5Y Monthly)	0.86
PE Ratio (TTM)	12.83
EPS (TTM)	0.2900
Earnings Date	Mar 08, 2022 - Mar 14, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	6.71

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

97% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BDSI

Learn more

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

BioDelivery Sciences Internatio
Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. Geographically, just over half of total sales are generated in the United States.
Rating
Fair Value
Economic Moat
17 hours agoMorningstar

All

News

Press Releases

Research Reports

Motley Fool
Why Shares of BioDelivery Sciences International Jumped 12.2% on Monday
Shares of the small pharmaceutical company, which focuses on pain management, have been rising since it released updated guidance late last week.
Zacks
BioDelivery (BDSI) Stock Up on Raised Guidance for 2021
BioDelivery Sciences International (BDSI) raises its financial guidance for full-year 2021. BDSI expects sales at the high end of its previous guidance.
GlobeNewswire
BioDelivery Sciences Expects 2021 Revenue at the High End of Full Year Guidance
Total 2021 Net Revenue expected in the range of $165 -$167 million, as compared to previous guidance of $162-$167 million BELBUCA 2021 Net Sales expected to be in the range of $147 -$148 million, as compared to previous guidance of $144-$148 million 2021 EBITDA expected to be in the $40 - $45 million range as compared with previous guidance of <$40 million RALEIGH, N.C., Jan. 20, 2022 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical